Minimum Investment
₹139,000
Price Range
₹132 to ₹139
Lot Size
1000 shares
Issue Size
₹52 Cr
About the Company
Incorporated in August 2015, Bio Medica Laboratories specialises in manufacturing pharmaceutical parenteral formulations, producing a wide range of ethical drugs, generic drugs, and over-the-counter (OTC) medications in liquid and dry-powder injectable forms.der injectables. These injectables are available in both single-dose and multi-dose formats, serving the needs of both human and veterinary healthcare.
Bookbuilding IPO
IPO Objectives
- Repayment of loan
- Enhancement of its existing production capabilities by setting up of new manufacturing facility at the existing premises
- General Corporate Purposes
Important Dates
| Bid/Offer Opens On | 21-05-2026 |
| Bid/Offer Closes On | 25-05-2026 |
| Finalisation of Basis of Allotment | — |
| Initiation of Refunds | — |
| Credit of Shares to Demat | — |
| IPO Listing Date | — |
Grey Market Premium (GMP)
—
Registrar
Skyline Financial Services Pvt.Ltd.
Lead Managers
- Narnolia Financial Services Ltd.
Company Promoters
- Mr. Mukesh Mehta and Mr. Pradeep Mehta are the company promoters.\r\n
